Results 201 to 210 of about 2,326,882 (356)
THE USE OF RADIOACTIVE CARBON DIOXIDE TO MEASURE REGIONAL BLOOD FLOW IN THE LUNGS OF PATIENTS WITH PULMONARY DISEASE [PDF]
, 1961 John B. West +2 more
openalex +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To provide a comprehensive clinical and genetic characterization of individuals with arthrogryposis multiplex congenita (AMC), focusing on the distribution of genetic etiologies across the neuromuscular spectrum and comparing myogenic and neurogenic subtypes. Methods A total of 105 individuals with AMC were clinically and genetically
Florencia Pérez‐Vidarte +13 more
wiley +1 more source
Thoracic Ultrasound for Acute Dyspnea in Interstitial Lung Disease. [PDF]
J Clin MedBayeh BA +5 more
europepmc +1 more source
NMDAR‐Antibody Encephalitis Diagnosed With Primary Central Nervous System Lymphoma: A Case Series
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT N‐methyl‐D‐aspartate receptor‐antibody encephalitis (NMDAR encephalitis) is one of the most common forms of autoimmune encephalitis, with a paraneoplastic relationship described in approximately 38%. Primary central nervous system lymphoma (PCNSL) is a rare hematologic malignancy that is not often considered as the underlying neoplasm in this ...
Soo Hyun Ahn +4 more
wiley +1 more source
Lung transplantation for interstitial lung disease. [PDF]
Breathe (Sheff)Ronan NJ, Helly F, Murray MA.
europepmc +1 more source
GUY'S HOSPITAL. PHTHISIS PULMONALIS, AFFECTING THE LOWER LOBE OF THE RIGHT LUNG ; THIRD STAGE OF THE DISEASE [PDF]
Wilks
openalex +1 more source
STUDIES OF RESPIRATORY PHYSIOLOGY IN CHILDREN. VI. LUNG DIFFUSING CAPACITY, DIFFUSING CAPACITY OF THE PULMONARY MEMBRANE AND PULMONARY CAPILLARY BLOOD VOLUME IN CONGENITAL HEART DISEASE* [PDF]
, 1961 Giovanni Bucci, Charles D. Cook
openalex +1 more source
Cognitive and Patient‐Reported Outcome Measures in LGI‐1‐IgG Autoimmune Encephalitis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Clinical outcome measures for autoimmune encephalitis (AE) are not yet well defined. Cognitive outcome measures (CogOs) and patient‐reported outcomes (PROs) may capture the symptoms of AE, beyond clinician‐reported outcomes (ClinROs) (the Modified Rankin Scale [mRS] and Clinical Assessment Scale in Autoimmune Encephalitis [CASE ...
Tatchaporn Ongphichetmetha +8 more
wiley +1 more source